Epsilon M&A Deal Report - Sergal Gestió Ramadera
Transaction Multiples for the Valuation of Private Companies
Genus / Sergal Gestió Ramadera
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ||||||||
Current | ns | ns | ns |
Multiple available | |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
Date | Acquirer | Target | Country | Multiples | See details |
23/02/2017 | Genus | Hermitage Genetics Designated Activity Company | Ireland | ** | 116100 |
13/03/2024 | Advanced Medical Solutions Group | Peters Surgical | Hauts-De-Seine | *** | 116034 |
Source: Epsilon Research / EMAT